ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,103.39
      -1.00%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lipocine Inc (LPCN)

      7. Lipocine Inc (LPCN) News

      LPCN

      Lipocine (LPCN)

      Lipocine Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LPCN
      DateTimeSourceHeadlineSymbolCompany
      04/11/20247:00AMPR Newswire (US)Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityNASDAQ:LPCNLipocine Inc
      03/28/20248:00AMPR Newswire (US)Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with CirrhosisNASDAQ:LPCNLipocine Inc
      03/25/20248:00AMPR Newswire (US)Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
      03/07/20245:31PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      03/07/20248:00AMPR Newswire (US)Lipocine Announces Financial Results for the Full Year Ended December 31, 2023NASDAQ:LPCNLipocine Inc
      03/07/20246:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      03/07/20246:07AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:LPCNLipocine Inc
      03/06/20248:00AMPR Newswire (US)Lipocine to Present at 36th Annual Roth ConferenceNASDAQ:LPCNLipocine Inc
      03/06/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      02/12/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      02/06/20248:00AMPR Newswire (US)Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
      02/02/20248:00AMPR Newswire (US)Lipocine Announces Continued Commercialization of TLANDO® through Verity PharmaceuticalsNASDAQ:LPCNLipocine Inc
      01/18/20248:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      01/18/20248:00AMPR Newswire (US)Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and CanadaNASDAQ:LPCNLipocine Inc
      12/19/202310:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      12/19/20238:00AMPR Newswire (US)Lipocine to Present at Biotech Showcase 2024NASDAQ:LPCNLipocine Inc
      11/22/20234:15PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LPCNLipocine Inc
      11/13/20232:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      11/13/20232:45PMPR Newswire (US)Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver Meeting® 2023NASDAQ:LPCNLipocine Inc
      11/08/20231:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPCNLipocine Inc
      11/08/20239:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      11/08/20238:00AMPR Newswire (US)Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2023NASDAQ:LPCNLipocine Inc
      11/01/20239:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      11/01/20238:00AMPR Newswire (US)Lipocine to Present Clinical Data on LPCN 1148 at The Liver Meeting® 2023NASDAQ:LPCNLipocine Inc
      10/26/20239:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      10/26/20238:00AMPR Newswire (US)Lipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum DepressionNASDAQ:LPCNLipocine Inc
      10/23/20237:00PMPR Newswire (US)Lipocine to Present at the H.C. Wainwright Annual NASH Investor ConferenceNASDAQ:LPCNLipocine Inc
      10/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      09/19/20234:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
      09/19/20234:05PMPR Newswire (US)Lipocine to Present at the Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:LPCNLipocine Inc
       Showing the most relevant articles for your search:NASDAQ:LPCN